Michele W Tang

Summary

Publications

  1. pmc Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine
    Michele W Tang
    Division Infectious Diseases, Department of Medicine, Stanford University, California 94305, USA
    J Infect Dis 207:S70-7. 2013
  2. pmc A review of the virological efficacy of the 4 World Health Organization-recommended tenofovir-containing regimens for initial HIV therapy
    Michele W Tang
    Department of Medicine, Division of Infectious Diseases, Stanford University, California 94305 5107, USA
    Clin Infect Dis 54:862-75. 2012
  3. pmc HIV-1 antiretroviral resistance: scientific principles and clinical applications
    Michele W Tang
    Stanford University, Division of Infectious Diseases, Stanford, CA 94305 5107, USA
    Drugs 72:e1-25. 2012

Detail Information

Publications3

  1. pmc Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine
    Michele W Tang
    Division Infectious Diseases, Department of Medicine, Stanford University, California 94305, USA
    J Infect Dis 207:S70-7. 2013
    ..However, because resistance testing is rarely available in resource-limited settings, it is critical to identify the cross-resistance patterns associated with first-line stavudine failure...
  2. pmc A review of the virological efficacy of the 4 World Health Organization-recommended tenofovir-containing regimens for initial HIV therapy
    Michele W Tang
    Department of Medicine, Division of Infectious Diseases, Stanford University, California 94305 5107, USA
    Clin Infect Dis 54:862-75. 2012
    ..Further study of TDF/3TC/NVP is required before it is widely deployed for initial ARV therapy...
  3. pmc HIV-1 antiretroviral resistance: scientific principles and clinical applications
    Michele W Tang
    Stanford University, Division of Infectious Diseases, Stanford, CA 94305 5107, USA
    Drugs 72:e1-25. 2012
    ..Understanding the basic principles of HIV drug resistance is helpful in guiding individual clinical decisions and the development of ARV treatment guidelines...